Thyroid Disease Serum Repository

This study has suspended participant recruitment.
(Suspended by institution for further review)
Sponsor:
Information provided by (Responsible Party):
University of Arkansas
ClinicalTrials.gov Identifier:
NCT00592605
First received: December 27, 2007
Last updated: June 30, 2016
Last verified: June 2016
  Purpose

Thyroid disease is more common among females and is increasing in incidence.

Otolaryngology faculty members and residents will perform head and neck examinations as part of the subject's routine care. If the participant is noted to have thyroid disease, they will be asked if they would like to participate in the research portion by having approximately 10cc's of blood drawn. Faculty and staff will complete a data collection sheet that will contain demographic and clinical data.


Condition
Thyroid Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Thyroid Disease Serum Repository

Resource links provided by NLM:


Further study details as provided by University of Arkansas:

Primary Outcome Measures:
  • To gather demographic and cultural information on approximately 1000 men and women with thyroid disease between the years 2007 and 2012 at the University of Arkansas for Medical Sciences. [ Time Frame: 2007-2012 ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA
Serum

Estimated Enrollment: 1000
Study Start Date: May 2007
Estimated Study Completion Date: May 2017
Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Primary Care Clinic
Criteria

Inclusion Criteria:

  • Participants with benign or malignant thyroid disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00592605

Locations
United States, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205
Sponsors and Collaborators
University of Arkansas
Investigators
Principal Investigator: Brendan Stack, MD University of Arkansas
  More Information

Responsible Party: University of Arkansas
ClinicalTrials.gov Identifier: NCT00592605     History of Changes
Other Study ID Numbers: 84287 
Study First Received: December 27, 2007
Last Updated: June 30, 2016
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Thyroid Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 23, 2016